Dimer Instruments
Santa Barbara, US · Founded 2023 · Delaware corporation
Dimer Instruments develops high-performance scientific instruments for biopharmaceutical analysis, using light scattering and biophysical characterization technologies to accelerate drug development processes. The company serves pharmaceutical researchers and drug development teams.
Founders & leadership
DS
Dr. Stephen MinneChief Technology Officer
DM
Dr. Michael LarkinExecutive
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2024
▶$11MraisedJul 2026 · 1 investors · Other TechnologyRule 506(b)
▶$11MraisedJul 2026 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN C. MINNEExecutive Officer, Director
- MICHAEL I. LARKINExecutive Officer, Director
- CHRISTIAN SAUBERDirector
- Offering amount
- $11M
- Amount sold
- $11M
- Minimum investment
- $1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Dimer Instruments do?
- Dimer Instruments develops high-performance scientific instruments for biopharmaceutical analysis, using light scattering and biophysical characterization technologies to accelerate drug development processes. The company serves pharmaceutical researchers and drug development teams.
- How much funding has Dimer Instruments raised?
- Dimer Instruments has disclosed $11M raised across 1 round.
- Where is Dimer Instruments headquartered?
- Dimer Instruments is headquartered in Santa Barbara, US.